Russell Frank Company’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Russell Frank Company’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.35M	Buy	+122,376	New	+$401K	﹤0.01%	2043

Other funds holding CPXX

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Frank Company's CPXX Position: Q1 2016 in Review

Russell Frank Company opened a new position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q1 2016: 122,376 shares worth $1.35M. The stake represents ﹤0.01% of the portfolio and ranks #2043 among its holdings.

58 funds tracked by Wall St. Rank hold CPXX as of Q1 2016.

Russell Frank Company held 122,376 shares of CELATOR PHARMACEUTICALS INC. COMMON STOCK worth $1.35M as of Q1 2016.
CELATOR PHARMACEUTICALS INC. COMMON STOCK was a new Russell Frank Company position in Q1 2016.
CELATOR PHARMACEUTICALS INC. COMMON STOCK made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2043 holding.
58 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.